Silvant Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Silvant Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,689	Closed	-$296K	–	345
2019 Q3	$296K	Hold	15,689	–	–	0.06%	143
2019 Q2	$185K	Hold	15,689	–	–	0.03%	193
2019 Q1	$214K	Buy	+15,689	New	+$203K	0.04%	185

Silvant Capital Management's ALDR Position: Q4 2019 in Review

Silvant Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 15,689 shares — an estimated $296K sold.

Silvant Capital Management first reported a position in ALDR in Q1 2019 and held it in 3 quarters. The position peaked at $296K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Silvant Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Silvant Capital Management sold 15,689 Alder Biopharmaceuticals shares in Q4 2019, an estimated $296K.
Silvant Capital Management first reported a position in Alder Biopharmaceuticals in Q1 2019 and held it in 3 quarters.
Silvant Capital Management's Alder Biopharmaceuticals position peaked at $296K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Silvant Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.